Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry

Proteomics - Clinical Applications

Volumn 6, Issue 11-12, 2012, Pages 626-634

  Randall, Sarah A ^a   Mckay, Matthew J ^a   Pascovici, Dana ^a   Mahon, Kate ^b   Horvath, Lisa ^b   Clarke, Stephen J ^c   Molloy, Mark P ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Biological variation; Biomarker; Plasma; Protein; SRM

Indexed keywords

ALBUMIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID A PROTEIN; ANGIOTENSINOGEN; ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN C3; ARYLESTERASE; BIOLOGICAL MARKER; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; HAPTOGLOBIN; HEMOPEXIN; IMMUNOGLOBULIN G; KININOGEN; OROSOMUCOID; PLASMA PROTEIN; PREALBUMIN; PROTEOME; PROTHROMBIN; SERUM AMYLOID A; TRANSCORTIN; VITAMIN D BINDING PROTEIN;

ARTICLE; BLOOD SAMPLING; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS MONITORING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; QUANTITATIVE ASSAY; REACTION ANALYSIS; SELECTED REACTION MONITORING;

AMINO ACID SEQUENCE; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STABILITY; TIME FACTORS;

EID: 84871411392     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200039     Document Type: Article

References (23)

1. Lewandrowski, K., Chen, A, Januzzi, J., Cardiac markers for myocardial infarction. A brief review. Am. J. Clin. Pathol. 2002, 118 (Suppl), S93-S99.
2. Pepys, M. B. and Hirschfield, G. M., C-reactive protein: a critical update. J. Clin. Invest. 2003, 111, 1805-1812.
3. Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J. et al., MRM-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell Proteomics 2009, 8, 1860-1877.
4. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
5. Anderson, N. L., The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 2010, 56, 177-185.
6. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics 2006, 5, 573-588.
7. McKay, M. J., Sherman, J., Laver, M. T., Baker, M. S. et al., The development of multiple reaction monitoring assays for liver-derived plasma proteins. Proteomics Clin. Appl. 2007, 1, 1570-1581.
8. Randall, S. A., McKay, M. J., Baker, M. S., Molloy, M. P. et al., Evaluation of blood collection tubes using selected reaction monitoring MS: implications for proteomic biomarker studies. Proteomics 2011, 11, 4593.
9. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B 1995, 57, 289-300.
10. R Development Core Team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria 2009.
11. Corzett, T. H., Fodor, I. K., Choi, M. W., Walsworth, V. L. et al., Statistical analysis of variation in the human plasma proteome. J. Biomed. Biotechnol. 2010, 2010, 258494.
12. Corzett, T. H., Fodor, I. K., Choi, M. W., Walsworth, V. L. et al., Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. J. Proteome Res. 2006, 5, 2611-2619.
13. Pakharukova, N. A., Pastushkova, L. Kh., Trifonova, O. P., Pyatnitsky, M. A. et al., Optimization of serum proteome profiling of healthy humans. Hum. Physiol. 2009, 35, 350-356.
14. Pakharukova, N. A., Pastushkova, L. Kh., Trifonova, O. P., Moshkovskii, S. A. et al., Variability of low-molecular-weight serum subproteome in healthy humans under the conditions of normal vital activity. Hum. Physiol. 2011, 37, 193-199.
15. Nelsestuen, G. L., Zhang, Y., Martinez, M. B., Key, N. S. et al., Plasma protein profiling: unique and stable features of individuals. Proteomics 2005, 5, 4012-4024.
16. Westgard, J., Desirable Specifications for Total Error, Imprecision, and Bias, Derived from Intra- and Inter-Individual Biologic Variation, in http://www.westgard.com/biodatabase1.htm 2012, Westgard QC.
17. Ricós, C., Alvarez, V., Cava, F., García-Lario, J. V. et al., Current databases on biological variation: pros, cons and progress. Scand. J. Clin. Lab. Invest. 1999, 59, 491-500.
18. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S. et al., A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 2011, 10, M110.006353.
19. Haab, B. B., Geierstanger, B. H., Michailidis, G., Vitzthum, F. et al., Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 2005, 5, 3278-3291.
20. Hortin, G. L., Sviridov, D., Anderson, N. L., High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54, 1608-1616.
21. Polanski, M., Anderson, N. L., A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights 2007, 2, 1-48.
22. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T. et al., The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell Proteomics 2004, 3, 311-326.
23. Regnier, F. E., Skates, S.J., Mesri, M., Rodriguez, H. et al., Protein-based multiplex assays: mock presubmissions to the US food and drug administration. Clin. Chem. 2010, 56, 165-171.